JS

Janardhan Sambhaji Daphal

Active Director Director DIN 10853861
DIN 10853861 First appointment Nov 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Janardhan Sambhaji Daphal

Data last updated:

Janardhan Sambhaji Daphal is a Director at Shri Firangai Multispeciality Hospital Private Limited (since 2024).

DIN 10853861
Primary Designation Director
First Appointment 28 Nov 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Nov 20242024Active

Directorship timeline

Open interactive timeline →
Shri Firangai Multispeciality Hospital Private Limited
Premium access

Shareholding and investment profile for Janardhan Sambhaji Daphal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Janardhan Sambhaji Daphal

Janardhan Sambhaji Daphal currently holds 1 directorship: Shri Firangai Multispeciality Hospital Private Limited (Director, since 28 Nov 2024).

Janardhan Sambhaji Daphal was first appointed on 28 Nov 2024 as Director at Shri Firangai Multispeciality Hospital Private Limited.

The current boards of Janardhan Sambhaji Daphal's companies include Mohan Bhagawan Gawand (Shri Firangai Multispeciality Hospital Private Limited), Navnath Ashru Satpute (Shri Firangai Multispeciality Hospital Private Limited), Sunil Zumber Bhagwat (Shri Firangai Multispeciality Hospital Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available